Tag: carcinoid blogs
New England Carcinoid Connection Announces June 2014 Conference for the Carcinoid and Neuroendocrine Tumor Community
Carcinoid and neuroendocrine cancer patients, family members, caregivers, and healthcare professionals are invited to attend the New England Carcinoid Connection Conference on Friday, June 27, 2014 at The Lantana in Randolph, Massachusetts. The…
READ MORENeuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting
Josh Mailman, President of the NorCal CarciNET Community and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…
READ MOREGallium-68 Scan Coming to NOLANETS for Carcinoid and Neuroendocrine Tumor Patients
Dr. Eugene A. Woltering has announced that the Gallium-68 DOTATATE PET/CT scan is going to be available beginning in the summer of 2014 through The New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS) Neuroendocrine Tumor Program at …
READ MORELuncheon with the Experts in New York City — Carcinoid and Neuroendocrine Tumor Patients Are Invited!
The Big Apple Noids support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and three medical experts for lunch on Sunday, May 4 from 12:30 to 3:30 pm in a private dining room at Dorrian’s restaurant in Manhattan…
READ MORECarcinoid and Neuroendocrine Tumor Specialist Dr. Eugene A. Woltering Named Chair of AJCC Expert Panel
Eugene A. Woltering, MD, The James D. Rives Professor of Surgery and Neuroscience and Director of Surgical Research at LSU Health Sciences Center/Ochsner in Kenner, Louisiana, has been selected to serve as Chair of the Neuroendocrine Tumors (NETs) …
READ MORENew OncLive TV Series Focuses on Pancreatic Neuroendocrine Tumors
Pancreatic neuroendocrine tumors, also known as pNETs, form in the hormone-making cells (islet cells) of the pancreas. In this new OncLive TV series, moderator Matthew Kulke, MD, Director of the Program in Neuroendocrine and Carcinoid Tumors at Dana-Farber/Brigham…
READ MORENovartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program
A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.
With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…
READ MOREFirst Meeting of New Southern Carcinoid and NET Support Group in Tennessee
All interested members of the carcinoid/neuroendocrine tumor community are invited to attend the first meeting of the newly formed Southern Carcinoid and NET Support Group, serving the community in Tennessee, Kentucky and Mississippi.
READ MOREFirst Ever Global Survey for Carcinoid & Neuroendocrine Tumor (NET) Patients
Participate in the first ever global survey specifically focused on NET (neuroendocrine tumor) cancer!
Please help the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation – both members of the International Neuroendocrine Cancer…
READ MOREMultiple Endocrine Neoplasia (MEN) Patient and Family Seminar in Chicago
Multiple Endocrine Neoplasia 1 and 2 patients and their families are invited to a free, half-day education seminar on Saturday, March 22, 2014, presented by the Lurie Cancer Center of Northwestern University in Chicago, Illinois and American Multiple…
READ MORE